BiotechTube
Overture Life

Overture Life

Barcelona, Spain· Est.
overture.life
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15.7M

Overview

Founded in 2019 in Barcelona, Overture Life is a private, pre-revenue company pioneering the automation of IVF through an integrated AI and robotics platform. The company's core technology aims to objectively select the most viable embryos and automate manual laboratory tasks, addressing key bottlenecks in fertility care. By potentially improving success rates and reducing costs, Overture targets the large and growing global IVF market. Its progress is supported by venture capital backing and strategic collaborations within the reproductive health sector.

Reproductive HealthFertility

Technology Platform

Integrated AI (computer vision, deep learning) and robotics platform for automating in vitro fertilization (IVF) laboratory workflows, including embryo selection and manipulation.

Funding History

2
Total raised:$15.7M
Series A$12M
Seed$3.7M

Opportunities

The large and growing global IVF market, driven by delayed parenthood and rising infertility rates, presents a significant addressable opportunity.
Clinics face pressure to improve success rates and operational efficiency, creating strong demand for disruptive automation and AI decision-support tools.
Overture's integrated platform could become a standard for next-generation fertility labs.

Risk Factors

The company faces stringent regulatory pathways for its medical devices and software.
Clinical adoption may be slow in the conservative field of embryology, requiring robust validation data.
Significant technical execution risk exists in developing and integrating complex robotics and AI systems for delicate biological procedures.

Competitive Landscape

Competition includes other AI-based embryo selection software companies (e.g., Fairtility, Alife Health) and established embryology media/equipment companies exploring automation. Overture differentiates by pursuing full-stack laboratory automation (robotics + AI), rather than a software-only solution, aiming to control the entire IVF workflow.

More companies in Biologics / Biosimilars →More companies in Spain →